Carotid Stenting and the Prevention of StrokePosted on February 21, 2010
Demetrius Lopes, MD, endovascular neurosurgeon at Rush University Medical Center, is one of the leaders in the country using carotid artery stenting to prevent stroke. Dr. Lopes and his team at Rush have participating in most of the clinical trials surrounding the carotid artery stenting technique and technology. A recent study published in Circulation: Cardiovascular Interventions take a look at a large cohort of symptomatic patients that were treated outside of a clinical trial. This “real world” experience, so to speak, reveals an optimal approach to carotid artery stenting, including:
– Use of clopidogrel (Plavix)
– Use of statins (cholesterol lowering agents)
– Use of embolic protection devices
– Leaving less than 50% residual stenosis
Dr. Lopes notes that the aforementioned criteria were stipulated when treating patients during the clinical trials, but he has also incorporated all of these precautions into his standard treatment regime at Rush University Medical Center.
Study publications, such as this one, however, are critical in justifying the use of the extra inpatient management techniques, including administration of Plavix and statins. This study helps to recognize that comprehensive stroke prevention care is a combination of procedural intervention and optimal medical management. Stroke treatment specialists, like Dr. Lopes, agree that the prevention of stroke is a complex task and a more “complete” approach is needed. This study is the first step in identifying some factors for optimal management of patients plagued with carotid artery stenosis. Dr. Lopes is committed to remaining on the forefront of these therapies.
If you have any questions regarding carotid artery stenosis and stenting, Dr. Lopes welcomes you to comment to this post below. Furthermore, he welcomes emails at info@ChicagoStrokeMD.com